What's known on the subject? and What does the study add?
Introduction
The tumor-node-metastasis (TNM) primary tumor staging classification is an internationally accepted and widely used tool to determine the anatomical extent of cancer spread. TNM classification system categorizes tumors on the basis of primary tumor characteristics (T), the presence or absence of regional lymph node involvement (LNI) (N), and the presence or absence of distant metastases (M) including non-regional LNIs. It is an essential part of the reports for the assessment of the prognosis of malignancies.
The major changes in renal cell carcinoma (RCC) in the 2010 American Joint Committee on Cancer TNM (7 th edition) with respect to 2002 version were re-classification of ipsilateral adrenal involvement from pT3a to pT4, and renal vein involvement (RVI) from pT3b to pT3a. Also, pT2 tumors were subdivided into tumors greater than 7 cm and less than 10 cm into pT2a and tumor limited to kidney and greater than 10 cm into pT2b groups (1) . LNI was simplified as yes or no regardless of a single or multiple LNI as in 2002 version.
The objective of the present study was to evaluate cancerspecific survival (CSS) in RCC patients operated by the surgeons member of the Urooncology Association of Turkey Renal Cancer-Study Group (UATRC-SG) and assess the concordance of 2002 and novel 2010 TNM primary tumor classifications.
Materials and Methods
A retrospective analysis of RCC registries from 25 member institutions of the UATRC-SG was performed. These centers contributed with their data from all patients who underwent radical or partial nephrectomy between 1987 and 2007 for kidney tumors and had no evidence of metastasis at the time of surgery. Decision, either for partial or radical nephrectomy was made on the discretion of the operating surgeon.
A total of 1889 patients had been operated and 198 of them underwent partial nephrectomy. Patients with von HippelLindau disease and synchronous bilateral tumors were not included in the database. Collected data from all centers were pooled in a single database. For the purposes of this study, the contents of the data consisted of patients' date of birth, gender, presence of systemic symptom, presentation, surgical approach, pathological size, perinephric fat invasion (PNI), RVI, adrenal invasion, invasion beyond Gerota's fascia, LNI, pathological T and N stage (2002 TNM), Fuhrman nuclear grade, histological tumor type, adjuvant treatment, recurrence, vital status, date of death, cause of death, and date of last follow-up parameters. The data was originally recorded with 2002 TNM classification. For the purposes of this study, patients' pT stages were re-assigned into 2010 TNM stage. Consequently, the database consisted of 1889 patients.
Five centers submitted more than 100 patients, 11 submitted 50 to 100, and 9 submitted less than 50 patients. Overall, 45.05% (n=851) of patients were submitted by 5 centers that provided data on more than 100 cases. The number of patients operated before 1997, between 1997 and 2002, and after 2002 were 82 (4.34%), 389 (20.59%) and 1418 (75.07%), respectively (Table  1) . Patients from all centers were included regardless of the participant center's patient volume in this study.
Apart from minor differences in clinical practice, common follow-up protocol included physical examination, serum blood urea nitrogen and creatinine determination, chest and abdominal computed tomography scanning every 6 months for 2 years and annually thereafter.
The underlying cause of death was obtained from death certificates and medical records. In the absence of any of these, telephone conversation with patients' relatives was used to determine the time and cause of death. 
Statistical Analysis
The results were expressed as means ± standard deviation and median [interquartile range (IQR)]. All evaluated variables except for age and pathological tumor size were categorical. Patients were censored at the time of death for other reasons or last follow-up. Patients were considered as failed if they died of RCC. Survival probability was estimated using the KaplanMeier method. Log-rank test was used to compare CSS between the groups. CSS was calculated for median survival time and 5-year survival. Trend test was constructed using the log-rank test. Concordance index was used to further compare the predictive ability of the 2002 and 2010 TNM classifications (2) . Univariable and multivariable analyses were performed with Cox proportional hazards regression model and 95% confidence intervals (CIs) were calculated. All analyses were performed using STATA 12.0 statistical software package (Stata Corp, Texas, USA). Statistical significance was set at 0.05 and all tests were two-tailed.
Results
A total of 1889 patients operated for RCC were included in this study. Clinical and pathological features of these patients are summarized in Table 2 . Median follow-up time was 25 months (IQR: 11.2-47.8) for the whole cohort and 25.4 months (IQR: 11.8-48.8) for the surviving patients. Of all, 151 (8%) patients died from RCC at a median follow-up of 20.4 months (IQR: 7.1-36) and 73 (3.9%) died from other causes. Seven hundred eighty-two patients (41.4%) who were alive at last follow-up had fewer than 24 months of follow-up. Death due to disease was observed in 79.5% of the patients (120/151) with in the first 2 years. A total of 311 patients (16.5%) had been followed for more than 60 months. Recurrent disease was seen in 208 patients (13.7%). Adjuvant treatment was given to 106 patients (9.9%).
The 2-year CSS rates for pT1a, pT1b, pT2a, pT2b, pT3a, pT3b and pT4 tumors were 98% (95% CI Figure 1 ). No CSS outcome was provided for pT3b stage group at 5 years since there was no patient followed up for more than 52 months in the group. No patient was registered for stage pT3c disease.
Pairwise CSS comparisons for consecutive T stages according to 2010 TNM classification between pT1a-pT1b (p=0.022), pT1b-pT2a (p=0.030), pT3a-pT3b (p<0.001) and pT3b-pT4 (p=0.020) were statistically significant. However, pairwise comparisons between pT2a-pT2b (p=0.070) and pT2b-pT3a (p=0.314) were not statistically significant. When 1761 patients without LNI (Figure 2 ). However, RVI only group had statistically significantly better CSS than RVI + PNI group (HR: 8.52 95% CI: 1.1-67.6 p=0.043). When lymph node-positive 38 patients were excluded, CSS differences between all subgroups were not statistically significant (data not shown).
The pT3b category consisted of 40 patients and 20 (50%) had infradiaphragmatic vena cava involvement (IVCI) only. Both PNI and IVCI were present in 20 patients (50%). Patients who had PNI + IVCI had poorer CSS compared to IVCI only patients (HR: 4.98 95% CI: 1.1-22.6 p=0.015). When 8 lymph node-positive patients were excluded, this statistically significant difference was lost (p=0.089).
A total of 121 patients were in the pT4 category. Forty-eight patients had invasion beyond Gerota's fascia and 73 patients had ipsilateral continuous adrenal invasion. No statistically significant difference was noted in CSS between Gerota's fascia invasion and adrenal invasion subgroups (HR: 1.14 p=0.75). When lymph node-positive patients were excluded, analysis on a total of 41 patients also resulted in non-significant difference (p=0.73).
On the univariable Cox regression analysis, age, gender, mode of presentation, type of surgery, histological tumor type, tumor size, pT stage, lymph node invasion, and Fuhrman nuclear grade all emerged as significant prognostic factors for CSS (Table  3) Figure 2 . Cancer-specific survival probability for pT3a according to renal vein and/or perinephric involvement independent prognostic factor for CSS (p for trend=0.002) (Table 3) . However, when pT1a stage was used as a reference, pT1b stage was not an independent prognostic factor (HR: 1.9 p=0.211). In the final model, C-indexes for 2002 and 2010 TNM classifications were 0.8683 and 0.8706, respectively. When only 1731 N0 patients were considered, the pT stage retained its significance as an independent prognostic factor (p for trend=0.011).
Discussion
Prediction of CSS is one of the main issues for malignant diseases. The TNM primary tumor classification system is a widely used, validated tool for this purpose (3). This classification system is a common ground for evaluating the anatomical extent of malignancies.
In the present study, analysis revealed that some of the changes made between T stages in 2010 TNM classification improved prediction of CSS for RCC.
The change in pT2 stage in 2010 TNM classification is a topic still under debate. This change was based on a single study (4) . In this study, results of 544 patients were evaluated and a 10 cm cut-off point was assigned for the subdivision of pT2 patients into pT2a and pT2b. However, other studies did not support a 10 cm cut-off for pT2 group (5, 6, 7, 8) . In a detailed analysis of pT2 group, Brookman-May et al. (5) reported that neither a cut-off value of 10 cm nor alternative cut-off values (8, 9, 11, 12, 13 cm) had an impact on CSS. In another study, a cut-off value of 11 cm was offered for the subdivision of pT2a and b (9) . It is argued that tumor aggressiveness features, as collecting system invasion in one study, may be more important than tumor size alone in the determination of prognosis (5) . The present study also revealed no statistically significant difference in CSS between 2010 pT2a and pT2b TNM stages, similar to the other previously reported series (5, 6, 7, 8) . Additionally, T2b-T3a patients had similar prognosis in the present study cohort. This may be due to the small number of patients with fewer failures in T2b group.
In 2005, Thompson et al. (10) reported that in the 2002 TNM classification, pT3a patients had unfavorable prognosis because of ipsilateral adrenal involvement when compared with pT3a patients with PNI only. In addition, prognosis in these patients with adrenal involvement was similar to that in pT4 group. Based on this data, patients with ipsilateral adrenal involvement were placed into pT4 group in the 2010 TNM classification. In the same study in pT3b group, patients with PNI died twice as likely as not PNI cases. Based on this observation concerning PNI status and level of tumor thrombus, a new classification for pT3 patients was offered (10) as follows: pT3a (RVI only), pT3b (PNI only), pT3c (PNI or IVCI), and pT3d (PNI + IVCI or VCI above . In another study, the novel 2010 TNM classification was validated (11) . In this study, pT3a patients were subdivided as (a) PNI invasion only, (b) RVI only, and (c) PNI + RVI. RVI only group had the most favorable outcome, followed by PNI and, RVI + PNI had the worst CSS. Furthermore, patients with pT3b disease were subdivided into IVCI and PNI + IVCI subgroups, where PNI + IVCI had significantly worse CSS than IVCI alone (11) . In the present study, the cohort had different characteristics unlike in the previously stated studies for 2010 pT3a group. Approximately 80% of the patients had only PNI.
In the pT3b group, distribution of PNI only and PNI + IVCI were equal. Patients with IVCI had statistically significantly better CSS than IVCI + PNI group. When lymph node-positive patients were excluded, these statistically significant CSS differences disappeared in both pT3a and pT3b groups. This is mainly due to the fact that overwhelming majority (72%) of the patients with LNI also had advanced pT stages (pT3-4). The LNI was also an independent prognostic factor ( Table 3) . PNI with IVCI or RVI has a poor prognosis. On the other hand, PNI only and RVI only patients have similar prognostic outcomes ( Figure 2 ). In this regard, simultaneous extension into two different anatomical sites (PNI and RVI or IVCI) appears to trigger a rapid progression in disease. Our results confirmed that PNI + IVCI or PNI +RVI worsened the prognosis in TNM 2010 pT3a and pT3b subgroups (10, 11) . In this context, relative influence of PNI on RVI and IVCI should be seriously considered in the subdivision of pT3a and pT3b groups in the new versions of the TNM classification.
CSS comparison between pT3b and pT4 was statically significant in favor of pT4. The Kaplan-Meier survival estimates showed a steep decrease in pT3b group during the initial 30-month follow-up period (Figure 1 ). This may be a consequence of small number of patients (n=40) and some patients in pT3b group with minute vena cava wall invasion may be overlooked and classified as pT3b rather than pT3c. These results were also evident by wide CIs for both pT3b and pT4 groups. Considering the results of the other T stage groups, in adequate number of patients for both pT3b and pT4 groups, similar results may be obtained.
In the present study, we did not have any patients operated with tumor thrombus invading the vena cava above diaphragm or invading the wall of the vena cava. This is similar to the other RCC series in which patients classified in pT3c group also constitute a very small percentage ranging from 0.5% to 0.6% (7, 8, 11, 12) .
Study Limitations
The present study has some important limitations. The most important limitation is its retrospective design. The results from 25 institutions lead to heterogeneity in preoperative work-up, surgical practice and post-operative follow-up. Other limitations were short follow-up period, lack of central pathological review, small number of pT3b and lack of pT3c patients. Concern about our short follow-up time can be alleviated by the fact that although follow-up time is median 25 months, 79.5% of patients died from RCC before the 24 th months of follow-up. Renal sinus fat invasion was not included in the present study, as most of the pathology reports had not mentioned this status.
Conclusion
Both univariable and multivariable analyses revealed that the 2010 TNM classification had an independent prognostic value. When compared with the 2002 TNM classification, novel 2010 TNM classification slightly improved prognostic accuracy (11, 13) . Ease of use, accumulated knowledge, and wide spread use of TNM primary staging systems maintain its contribution to other predictive models (14, 15) .
The impact of recent targeted therapy agents on long-term prognosis is yet to be seen. In this regard, staging will continue to evolve in observance of the results with the use of these targeted agents.
Subdividing pT2 into pT2a and pT2b in the 2010 TNM classification does not have a CSS advantage. Moving ipsilateral adrenal involvement patients from pT3a to pT4 yielded a more accurate prognosis prediction in both pT3a and pT4 groups. T stage and LNI are independent prognostic factors for CSS in RCC.
Overall, the Turkish multi-institutional experience revealed that novel 2010 TNM classification is slightly improved over the former one. However, shown by C-index values, this improvement is not sufficient to state that the 2010 TNM outperforms the 2002 TNM.
